Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 3.29 is 28% above its estimated 4-year average of 2.56, near the high end of its estimated 4-year range (0.52–4.18).
As of 2026-10-06T14:52:36.415Z. 8.48% below its estimated 12-month average of 3.59.
Calculation as of: 2026-10-06T14:52:36.415Z.
Quote observation: 2026-10-06T14:50:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 60c60f9730168f961ae5802b8b984853ffa10d75cec87ff2fe3ca57d1f3eaeef
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
3.29
PS RATIO AVG TTM
3.59
PS RATIO AVG 3Y
2.38
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.48%
CURRENT VS 3Y AVG
+38.34%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.00
median of 426 covered companies
CURRENT VS SECTOR MEDIAN
-17.85%
vs the sector median at left
Market Cap
$4.37B
PS Ratio
20.63
TTM Avg
15.09
3Y Avg
15.20
5Y Avg
15.20
Market Cap
$4.43B
PS Ratio
14.38
TTM Avg
10.54
3Y Avg
6.93
5Y Avg
8.46
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.38B | 3.29 | 3.59 | 2.38 | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | 20.63 | 15.09 | 15.20 | 15.20 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.43B | 14.38 | 10.54 | 6.93 | 8.46 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.59B | N/A | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.13B | 2.81 | 2.71 | 2.39 | 2.70 |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 0.82 | 0.77 | 1.01 | 1.19 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | 2.93 | 2.20 | 2.14 | 2.77 |
| BillionToOne, Inc. (BLLN)vs › | $4.70B | 11.83 | 14.66 | 14.66 | 14.66 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | 2480.03 | 1806.21 | 686.61 | 531.46 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $314,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $358,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $316,999,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $343,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $1,331,999,999 |
Current P/S: $4,384,305,507 market capitalization ÷ $1,331,999,999 TTM revenue = 3.29x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:50:22.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 3.29, P/S is above its estimated 4-year median — higher than 72% of readings in its estimated 4-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 4-year low
0.52
median
2.69
estimated 4-year high
4.18
P/S Ratio
3.29
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 3.49 |
| 2026-10-02 | 3.46 |
| 2026-10-01 | 3.43 |
| 2026-09-30 | 3.47 |
| 2026-09-29 | 3.54 |
| 2026-09-28 | 3.57 |
| 2026-09-25 | 3.47 |
| 2026-09-24 | 3.49 |
| 2026-09-23 | 3.48 |
| 2026-09-22 | 3.50 |
| 2026-09-21 | 3.44 |
| 2026-09-18 | 3.38 |
| 2026-09-17 | 3.46 |
| 2026-09-16 | 3.33 |
| 2026-09-15 | 3.31 |
| 2026-09-14 | 3.34 |
| 2026-09-11 | 3.34 |
| 2026-09-10 | 3.34 |
| 2026-09-09 | 3.37 |
| 2026-09-08 | 3.32 |
| 2026-09-04 | 3.38 |
| 2026-09-03 | 3.37 |
| 2026-09-02 | 3.39 |
| 2026-09-01 | 3.35 |
| 2026-08-31 | 3.38 |
| 2026-08-28 | 3.38 |
| 2026-08-27 | 3.42 |
| 2026-08-26 | 3.47 |
| 2026-08-25 | 3.48 |
| 2026-08-24 | 3.50 |
| 2026-08-21 | 3.57 |
| 2026-08-20 | 3.66 |
| 2026-08-19 | 3.78 |
| 2026-08-18 | 3.82 |
| 2026-08-17 | 3.78 |
| 2026-08-14 | 3.78 |
| 2026-08-13 | 3.70 |
| 2026-08-12 | 3.75 |
| 2026-08-11 | 3.72 |
| 2026-08-10 | 3.73 |
| 2026-08-07 | 3.76 |
| 2026-08-06 | 3.75 |
| 2026-08-05 | 3.75 |
| 2026-08-04 | 3.53 |
| 2026-08-03 | 3.73 |
| 2026-07-31 | 4.00 |
| 2026-07-30 | 4.02 |
| 2026-07-29 | 4.01 |
| 2026-07-28 | 4.10 |
| 2026-07-27 | 4.00 |
| 2026-07-24 | 4.05 |
| 2026-07-23 | 4.05 |
| 2026-07-22 | 4.04 |
| 2026-07-21 | 4.04 |
| 2026-07-20 | 3.91 |
| 2026-07-17 | 4.05 |
| 2026-07-16 | 4.06 |
| 2026-07-15 | 4.09 |
| 2026-07-14 | 4.02 |
| 2026-07-13 | 4.02 |
| 2026-07-10 | 4.05 |
| 2026-07-09 | 4.13 |
| 2026-07-08 | 4.09 |
| 2026-07-07 | 4.08 |
| 2026-07-06 | 4.00 |
| 2026-07-02 | 3.98 |
| 2026-07-01 | 4.02 |
| 2026-06-30 | 4.10 |
| 2026-06-29 | 4.12 |
| 2026-06-26 | 4.18 |
| 2026-06-25 | 4.13 |
| 2026-06-24 | 4.14 |
| 2026-06-23 | 3.99 |
| 2026-06-22 | 3.83 |
| 2026-06-18 | 3.83 |
| 2026-06-17 | 3.79 |
| 2026-06-16 | 3.80 |
| 2026-06-15 | 3.84 |
| 2026-06-12 | 3.85 |
| 2026-06-11 | 3.81 |
| 2026-06-10 | 3.81 |
| 2026-06-09 | 3.82 |
| 2026-06-08 | 3.74 |
| 2026-06-05 | 3.76 |
| 2026-06-04 | 3.74 |
| 2026-06-03 | 3.54 |
| 2026-06-02 | 3.37 |
| 2026-06-01 | 3.49 |
| 2026-05-29 | 3.60 |
| 2026-05-28 | 3.66 |
| 2026-05-27 | 3.71 |
| 2026-05-26 | 3.78 |
| 2026-05-22 | 3.75 |
| 2026-05-21 | 3.74 |
| 2026-05-20 | 3.76 |
| 2026-05-19 | 3.70 |
| 2026-05-18 | 3.65 |
| 2026-05-15 | 3.67 |
| 2026-05-14 | 3.78 |
| 2026-05-13 | 3.83 |
| 2026-05-12 | 3.83 |
| 2026-05-11 | 3.88 |
| 2026-05-08 | 3.95 |
| 2026-05-07 | 3.96 |
| 2026-05-06 | 4.06 |
| 2026-05-05 | 3.96 |
| 2026-05-04 | 3.89 |
| 2026-05-01 | 3.76 |
| 2026-04-30 | 3.71 |
| 2026-04-29 | 3.44 |
| 2026-04-28 | 3.47 |
| 2026-04-27 | 3.46 |
| 2026-04-24 | 3.35 |
| 2026-04-23 | 3.34 |
| 2026-04-22 | 3.37 |
| 2026-04-21 | 3.25 |
| 2026-04-20 | 3.27 |
| 2026-04-17 | 3.30 |
| 2026-04-16 | 3.18 |
| 2026-04-15 | 3.28 |
| 2026-04-14 | 3.32 |
| 2026-04-13 | 3.19 |
| 2026-04-10 | 3.08 |
| 2026-04-09 | 3.26 |
| 2026-04-08 | 3.22 |
| 2026-04-07 | 3.07 |
| 2026-04-06 | 3.07 |
| 2026-04-02 | 3.07 |
| 2026-04-01 | 3.09 |
| 2026-03-31 | 3.07 |
| 2026-03-30 | 2.90 |
| 2026-03-27 | 2.92 |
| 2026-03-26 | 3.02 |
| 2026-03-25 | 3.05 |
| 2026-03-24 | 2.90 |
| 2026-03-23 | 2.96 |
| 2026-03-20 | 2.95 |
| 2026-03-19 | 3.07 |
| 2026-03-18 | 3.08 |
| 2026-03-17 | 3.16 |
| 2026-03-16 | 3.12 |
| 2026-03-13 | 3.14 |
| 2026-03-12 | 3.11 |
| 2026-03-11 | 3.31 |
| 2026-03-10 | 3.36 |
| 2026-03-09 | 3.29 |
| 2026-03-06 | 3.25 |
| 2026-03-05 | 3.23 |
| 2026-03-04 | 3.24 |
| 2026-03-03 | 3.11 |
| 2026-03-02 | 3.22 |
| 2026-02-27 | 3.30 |
| 2026-02-26 | 3.68 |
| 2026-02-25 | 3.67 |
| 2026-02-24 | 3.61 |
| 2026-02-23 | 3.60 |
| 2026-02-20 | 3.70 |
| 2026-02-19 | 3.76 |
| 2026-02-18 | 3.75 |
| 2026-02-17 | 3.80 |
| 2026-02-13 | 3.78 |
| 2026-02-12 | 3.69 |
| 2026-02-11 | 3.72 |
| 2026-02-10 | 3.65 |
| 2026-02-09 | 3.70 |
| 2026-02-06 | 3.75 |
| 2026-02-05 | 3.76 |
| 2026-02-04 | 3.75 |
| 2026-02-03 | 3.87 |
| 2026-02-02 | 3.82 |
| 2026-01-30 | 3.86 |
| 2026-01-29 | 3.79 |
| 2026-01-28 | 3.82 |
| 2026-01-27 | 3.79 |
| 2026-01-26 | 3.67 |
| 2026-01-23 | 3.60 |
| 2026-01-22 | 3.66 |
| 2026-01-21 | 3.60 |
| 2026-01-20 | 3.60 |
| 2026-01-16 | 3.55 |
| 2026-01-15 | 3.59 |
| 2026-01-14 | 3.67 |
| 2026-01-13 | 3.71 |
| 2026-01-12 | 3.77 |
| 2026-01-09 | 3.87 |
| 2026-01-08 | 3.88 |
| 2026-01-07 | 3.92 |
| 2026-01-06 | 3.95 |
| 2026-01-05 | 3.96 |
| 2026-01-02 | 3.90 |
| 2025-12-31 | 3.92 |
| 2025-12-30 | 3.90 |
| 2025-12-29 | 3.97 |
| 2025-12-26 | 3.96 |
| 2025-12-24 | 3.95 |
| 2025-12-23 | 3.97 |
| 2025-12-22 | 3.98 |
| 2025-12-19 | 3.85 |
| 2025-12-18 | 3.88 |
| 2025-12-17 | 3.93 |
| 2025-12-16 | 3.86 |
| 2025-12-15 | 3.85 |
| 2025-12-12 | 3.88 |
| 2025-12-11 | 3.91 |
| 2025-12-10 | 3.87 |
| 2025-12-09 | 3.93 |
| 2025-12-08 | 4.00 |
| 2025-12-05 | 3.84 |
| 2025-12-04 | 3.78 |
| 2025-12-03 | 3.72 |
| 2025-12-02 | 3.71 |
| 2025-12-01 | 3.67 |
| 2025-11-28 | 3.67 |
| 2025-11-26 | 3.66 |
| 2025-11-25 | 3.62 |
| 2025-11-24 | 3.60 |
| 2025-11-21 | 3.58 |
| 2025-11-20 | 3.47 |
| 2025-11-19 | 3.56 |
| 2025-11-18 | 3.52 |
| 2025-11-17 | 3.43 |
| 2025-11-14 | 3.33 |
| 2025-11-13 | 3.26 |
| 2025-11-12 | 3.29 |
| 2025-11-11 | 3.39 |
| 2025-11-10 | 3.37 |
| 2025-11-07 | 3.42 |
| 2025-11-06 | 3.48 |
| 2025-11-05 | 3.50 |
| 2025-11-04 | 3.50 |
| 2025-11-03 | 3.41 |
| 2025-10-31 | 3.21 |
| 2025-10-30 | 3.07 |
| 2025-10-29 | 2.66 |
| 2025-10-28 | 2.62 |
| 2025-10-27 | 2.61 |
| 2025-10-24 | 2.65 |
| 2025-10-23 | 2.66 |
| 2025-10-22 | 2.62 |
| 2025-10-21 | 2.54 |
| 2025-10-20 | 2.56 |
| 2025-10-17 | 2.58 |
| 2025-10-16 | 2.60 |
| 2025-10-15 | 2.65 |
| 2025-10-14 | 2.59 |
| 2025-10-13 | 2.51 |
| 2025-10-10 | 2.51 |
| 2025-10-09 | 2.54 |
| 2025-10-08 | 2.54 |
| 2025-10-07 | 2.50 |
| 2025-10-06 | 2.39 |
| 2025-10-03 | 2.44 |
| 2025-10-02 | 2.45 |
| 2025-10-01 | 2.47 |
| 2025-09-30 | 2.54 |
| 2025-09-29 | 2.54 |
| 2025-09-26 | 2.52 |
| 2025-09-25 | 2.40 |
| 2025-09-24 | 2.41 |
| 2025-09-23 | 2.44 |
Showing the most recent 260 of 1,005 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
